Results 241 to 250 of about 6,129,049 (301)
Abstract Background Despite pre‐emptive treatment (PeT), cytomegalovirus (CMV) disease and reactivation remain a clinical concern. In Australia and New Zealand (ANZ), variability exists in the management of CMV for haematopoietic stem cell transplantation (HSCT) recipients.
Andrea Henden +13 more
wiley +1 more source
Safety of different amphotericin B formulations among AIDS patients with invasive fungal disease: a retrospective observational study. [PDF]
Tan Y +7 more
europepmc +1 more source
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. [PDF]
Hoenigl M +21 more
europepmc +1 more source
Multi-courses of blinatumomab combined with reduced dose chemotherapy has been successfully used in chemo-intolerant middle to high-risk pediatric B-ALL patients with invasive fungal disease. [PDF]
Zhou EM +14 more
europepmc +1 more source

